157 related articles for article (PubMed ID: 35777968)
1. Techniques for advanced glycation end product measurements for diabetic bone disease: pitfalls and future directions.
Sroga GE; Stephen SJ; Wang B; Vashishth D
Curr Opin Endocrinol Diabetes Obes; 2022 Aug; 29(4):333-342. PubMed ID: 35777968
[TBL] [Abstract][Full Text] [Related]
2. Advanced glycation and glycoxidation end products in bone.
Wang B; Vashishth D
Bone; 2023 Nov; 176():116880. PubMed ID: 37579812
[TBL] [Abstract][Full Text] [Related]
3. Induction and rescue of skeletal fragility in a high-fat diet mouse model of type 2 diabetes: An in vivo and in vitro approach.
LLabre JE; Sroga GE; Tice MJL; Vashishth D
Bone; 2022 Mar; 156():116302. PubMed ID: 34952229
[TBL] [Abstract][Full Text] [Related]
4. An advanced glycation endproduct (AGE)-rich diet promotes accumulation of AGEs in Achilles tendon.
Skovgaard D; Svensson RB; Scheijen J; Eliasson P; Mogensen P; Hag AM; Kjær M; Schalkwijk CG; Schjerling P; Magnusson SP; Couppé C
Physiol Rep; 2017 Mar; 5(6):. PubMed ID: 28336820
[TBL] [Abstract][Full Text] [Related]
5. Confocal Raman microscopy can quantify advanced glycation end product (AGE) modifications in Bruch's membrane leading to accurate, nondestructive prediction of ocular aging.
Glenn JV; Beattie JR; Barrett L; Frizzell N; Thorpe SR; Boulton ME; McGarvey JJ; Stitt AW
FASEB J; 2007 Nov; 21(13):3542-52. PubMed ID: 17567569
[TBL] [Abstract][Full Text] [Related]
6. Development of simultaneous quantitation method for 20 free advanced glycation end products using UPLC-MS/MS and clinical application in kidney injury.
Xu Y; Huang M; Chen Y; Yu L; Wu M; Kang S; Lin Q; Zhang Q; Han L; Lin H; Ke P; Fu W; Tang Q; Yan J; Huang X
J Pharm Biomed Anal; 2024 May; 242():116035. PubMed ID: 38367518
[TBL] [Abstract][Full Text] [Related]
7. In depth investigation of collagen non-enzymatic glycation by Raman spectroscopy.
Alsamad F; Brunel B; Vuiblet V; Gillery P; Jaisson S; Piot O
Spectrochim Acta A Mol Biomol Spectrosc; 2021 Apr; 251():119382. PubMed ID: 33461140
[TBL] [Abstract][Full Text] [Related]
8. Experimental Hyperglycemia Alters Circulating Concentrations and Renal Clearance of Oxidative and Advanced Glycation End Products in Healthy Obese Humans.
Perkins RK; Miranda ER; Karstoft K; Beisswenger PJ; Solomon TPJ; Haus JM
Nutrients; 2019 Mar; 11(3):. PubMed ID: 30823632
[TBL] [Abstract][Full Text] [Related]
9. Causative or associative: A critical review of the role of advanced glycation end-products in bone fragility.
Willett TL; Voziyan P; Nyman JS
Bone; 2022 Oct; 163():116485. PubMed ID: 35798196
[TBL] [Abstract][Full Text] [Related]
10. Bone microarchitecture, biomechanical properties, and advanced glycation end-products in the proximal femur of adults with type 2 diabetes.
Karim L; Moulton J; Van Vliet M; Velie K; Robbins A; Malekipour F; Abdeen A; Ayres D; Bouxsein ML
Bone; 2018 Sep; 114():32-39. PubMed ID: 29857063
[TBL] [Abstract][Full Text] [Related]
11. New biomarkers of Maillard reaction damage to proteins.
Wells-Knecht KJ; Brinkmann E; Wells-Knecht MC; Litchfield JE; Ahmed MU; Reddy S; Zyzak DV; Thorpe SR; Baynes JW
Nephrol Dial Transplant; 1996; 11 Suppl 5():41-7. PubMed ID: 9044306
[TBL] [Abstract][Full Text] [Related]
12. Non-invasive skin autofluorescence, blood and urine assays of the advanced glycation end product (AGE) pentosidine as an indirect indicator of AGE content in human bone.
Kida Y; Saito M; Shinohara A; Soshi S; Marumo K
BMC Musculoskelet Disord; 2019 Dec; 20(1):627. PubMed ID: 31881872
[TBL] [Abstract][Full Text] [Related]
13. Immunolocalization and quantification of advanced glycation end products in retinal neovascular membranes and serum: a possible role in ocular neovascularization.
Swamy-Mruthinti S; Miriam KC; Kumar SK; Biswas J; Ramakrishnan S; Nagaraj RH; Sulochana KN
Curr Eye Res; 2002 Sep; 25(3):139-45. PubMed ID: 12607183
[TBL] [Abstract][Full Text] [Related]
14. Accumulation of carboxymethyl-lysine (CML) in human cortical bone.
Thomas CJ; Cleland TP; Sroga GE; Vashishth D
Bone; 2018 May; 110():128-133. PubMed ID: 29408699
[TBL] [Abstract][Full Text] [Related]
15. Increased levels of advanced glycation end products in human cataractous lenses.
Franke S; Dawczynski J; Strobel J; Niwa T; Stahl P; Stein G
J Cataract Refract Surg; 2003 May; 29(5):998-1004. PubMed ID: 12781289
[TBL] [Abstract][Full Text] [Related]
16. Role of advanced glycation end products (AGEs) in osteoporosis in diabetes.
Yamagishi S
Curr Drug Targets; 2011 Dec; 12(14):2096-102. PubMed ID: 22023404
[TBL] [Abstract][Full Text] [Related]
17. Renal accumulation and clearance of advanced glycation end-products in type 2 diabetic nephropathy: effect of angiotensin-converting enzyme and vasopeptidase inhibition.
Wihler C; Schäfer S; Schmid K; Deemer EK; Münch G; Bleich M; Busch AE; Dingermann T; Somoza V; Baynes JW; Huber J
Diabetologia; 2005 Aug; 48(8):1645-53. PubMed ID: 16010524
[TBL] [Abstract][Full Text] [Related]
18. Role of advanced glycation end products in diabetic vascular injury: molecular mechanisms and therapeutic perspectives.
Liu J; Pan S; Wang X; Liu Z; Zhang Y
Eur J Med Res; 2023 Dec; 28(1):553. PubMed ID: 38042909
[TBL] [Abstract][Full Text] [Related]
19. Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure.
Miyata T; Wada Y; Cai Z; Iida Y; Horie K; Yasuda Y; Maeda K; Kurokawa K; van Ypersele de Strihou C
Kidney Int; 1997 Apr; 51(4):1170-81. PubMed ID: 9083283
[TBL] [Abstract][Full Text] [Related]
20. Effect of type 2 diabetes-related non-enzymatic glycation on bone biomechanical properties.
Karim L; Bouxsein ML
Bone; 2016 Jan; 82():21-7. PubMed ID: 26211993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
